|
|
|
Austrian Breast & Colorectal Cancer Study Group
Together with several close friends and collaborators throughout the country,
the Austrian Breast & Colorectal Cancer Study Group (ABCSG)
was founded
in the mid 1980's. A small enterprise with one single secretary developed to be an
internationally well reputed study group that has substantially contributed to therapeutical
developments for the benefit of patients with breast and colorectal cancer and has helped
establish novel therapy modalities.
As President, I headed the ABCSG for over twenty years. The list of entailing significant
scientific findings and activities include the following:
-
The distinction between patients with hormone-dependent and hormone-independent breast
cancer and between treatment strategies based on receptor status,
-
The implementation of chemotherapy before surgery (preoperative chemotherapy),
-
The inducement of a newly founded task force for research in sentinel
lymph node biopsy, the Austrian Sentinel Node Biopsy Study Group,
-
Follow-up for breast cancer patients,
-
Sound evidence for the value of aromatase inhibitors and drugs that have an
influence on ovarian function in premenopausal patients.
A final important event continues to be the annual ABCSG conference a venue that facilitated
intensive exchanges of ideas with many a colleague involved in breast cancer patients'
diagnostics and therapy. Many of the measures elaborated in this framework led to decisive
quality improvements in the treatment of such patients.
Over all these years with the ABCSG, I was guided by the principle of collegiality,
understanding for my patients fate and colleagues’ problems, compassionate leadership
combined with transparence and democratic decision-making, clarity of thought and tight
organization. Working in a group always gave me pleasure, and this has not changed, even
though increasing demands may in many respects make the establishment of new projects appear
considerably more complex than previously. These activities resulted in a series of
internationally renowned publications.
In the ABCSG as well as my other fields of work, particular attention has been paid to surgical
quality control which has been accompanied e.g. by an internationally renowned increase in
the rates of breast-conserving surgical interventions in Austria. These efforts are based
on an active degree of interdisciplinarity between surgery and other disciplines, incl. medical
oncology, gynecology, radiotherapy and pathology.
 
Austrian Society of Surgery
I served as President of the Austrian Society of Surgery
(Österreichische Gesellschaft für
Chirurgie, ÖGC) from 2005 to 2006. It was a particular pleasure for
me to contribute to and guide the ÖGC for that period. My presidency culminated in the
organization of the 47th Austrian Surgical Congress which convened in June 2006 at Viennas
Museumsquartier. Further details and several speeches can be found on the Societys homepage,
as indicated above.
 
Austrian Society of Senology
On September 9, 2006, I was elected for a two-year presidency of the Austrian Society of
Senology (Österreichische Gesellschaft für Senologie, ÖGS).
An interdisciplinary forum, the ÖGS deals with all aspects of breast diseases and health care.
The key aspects of my presidency were to elaborate guidelines for breast cancer screening
and quality control for sentinel lymph node biopsy. The Senology Congress of 2009 was
carried out in collaboration with the Swiss Society of Senology and took place in Vienna
in my term in office.
Breast Surgery International
I was elected President of Breast Surgery International (BSI) in 1999. This forum is a
worldwide association of surgeons who chiefly address themselves to patients with diseases
of the breast. BSI is integrated into the International Society of Surgery (ISS/SIC)
. The first postgraduate course for breast surgeons took place on the
occasion of the Societys 2005 Conference in Durban at which I was honored to deliver the
Umberto Veronesi Lecture. Further details are available at the BSI homepage.

One of my most essential concerns generally is to assist young colleagues from Europe and Asia
in the framework of such advanced postgraduate training courses in breast surgery. Organized by
BSI, the European Society of Surgical Oncology (ESSO),
the European Society of Mastology (EUSOMA) and other associations,
these courses aim at making prospective breast specialists familiar with the most modern
surgical techniques and treatments. Amongst others, this relates to predictive and prognostic
factors, surgical breast conservation and preoperative therapy. Apart from the Durban and Montreal Conferences,
such courses have recently also been offered in Kuwait, Lucknow, Budapest and Adelaide.
 
|
|
back
|
At the beginning of my scientific duties at the University Clinic of Surgery, one of my
concerns was to present my own scientific findings and results to the public, while making
known the present standards of knowledge and my own perspective on various problems in the
framework of advanced training events. Over the 2001-2009 period, I held a total of 181 talks
at international events, and another 132 in Austria. These international presentations were
given in the following countries: Australia, Belgium, Bosnia, Bulgaria, Canada, Colombia, Croatia, the Czech Republic,
Egypt, England, France, Germany, Greece, Hungary, India, Ireland, Italy, Japan, Jordan,
Kazakhstan, Korea, Kuwait, Lithuania, Malaysia, the Netherlands, Poland, Portugal, Russia, Scottland, Sweden,
Switzerland, Slovakia, Spain, South Africa, Thailand, Turkey, Ukraine, United Arab Emirates, the USA, and Yemen.
My international lecturing activities were crowned by lectures given at the American Society
of Clinical Oncology Annual Meeting (ASCO) and the annual San Antonio Breast Cancer Symposium (SABCS).
 
 
|
|
back
|
Already at the beginning of my activities at Vienna General Hospital, it was clear to me that
relevant knowledge would primarily be disseminated in the framework of scientific publications.
I published my first paper in 1978 together with Stefan Wuketich. In the meantime, 320articles
have been issued, totalling to an overall impact factor of 857.
|
|
back
|
American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) was founded in 1964 with
the objective to ensure optimal levels of therapeutic quality. Today, ASCO comprises
more than 20,000 medical members coming from various oncological disciplines surgeons,
specialists in internal medicine, radiologists, as well as general practitioners and care
specialists. The Society is the leading institution in the field of cancer research and
treatment; its annual meeting and organ, the Journal of Clinical Oncology,
today are the most influential fora of oncology.
European Society of Surgical Oncology
The European Society of Surgical Oncology (ESSO) is a cross-continental association of surgical
oncologists with the aim of optimizing the standards of surgical care by means of specialist
conferences and advanced training courses. Another focus of this Society is on
enhancing basic and clinical research in oncology.
Further activities
Apart from the societies that I served as president, I also belong to the
Society of Surgeons in Vienna (Gesellschaft der Chirurgen in Wien), the
Austrian Cancer Society
(Austrian Cancer Society), the German Society of Senology
(German Society of Senology), the German Cancer Society
(German Cancer Society), the German Adjuvant Breast Cancer Group, and others.
Furthermore, I was awarded honorary doctorates from Pleven Medical School in Bulgaria and St. Petersburg University, Russia.
|
|
back
|
St. Gallen Consensus Conference
The biennial Primary Therapy of Breast Cancer International Conference in St. Gallen,
Switzerland, is Europes most influential forum in terms of establishing guidelines for
breast cancer treatment and diagnostics. Virtually all collaborative study groups and
centers that specialize in basic and clinical research across the globe present their
most relevant findings to this forum. I myself was greatly honored in 2001 to join the
St. Gallen Plenum.
Early Breast Cancer Trialists Collaborative Group
I am also a Board Member of the Oxford-based Early Breast Cancer Trialists
Collaborative Group (EBCTCG). Founded in 1983, the objective of this internationally
staffed institution is to generate sound insights, through combined evaluations of a
multitude of clinically relevant patient data, into the efficacy of various forms of
medical breast cancer treatment, incl. hormonal and cytotoxic treatment, chemotherapy,
surgery and radiotherapy. The Groups results are currently validated by data accumulated
from 200,000 patients treated in 400 controlled randomized trials.
Breast Health Global Initiative
In the framework of my international activities, furthermore, I am a member of the
Breast Health Global Initiative (BHGI). The Initiatives
mission is to elaborate directives for breast health and cancer control for the benefit of
underprivileged communities guidelines that are evidence-based, economically feasible,
and adapted to the resp. countrys specifics. I have been participating in BHGI for
several years. The Initiative was brought into being along with the Fred Hutchinson
Cancer Research Center in Seattle and the Susan G. Komen Breast Cancer
Foundation and has held several conferences in Washington und New York.
The next Global Summit on International Breast Health will convene in Chicago in
June 2010; I shall be serving on the Scientific Advisory Board.
Oncopool
Coordinated from its headquarters in Nottingham, the Oncopool database is finally another
scientific project that aims at improving the incorporation of breast cancer research
results into clinical practice. The project is funded by the European Commission and is
supplied by leading centers. In the future, Oncopool will become the standard database for
scientific information regarding the distribution of prognostic factors, recurrence rates
and survival rates in connection with breast cancer.
|
|
back
|
Breast Care
I have been particularly pleased, since 2006, to collaborate with two German colleagues
as chiefs on the Editors Board of a Journal entitled Breast Care. This English-language magazine
represents a highly topical platform that serves to present and discuss all relevant aspects
in connection with breast cancer.
European Journal of Cancer
I also act as Breast Cancer Editor for the European Journal of Cancer (EJC), an international
oncology journal that is devoted to experimental cancer research, clinical oncology, and cancer
epidemiology and prevention;EJC is the
official organ of a number of European scientific oncological societies, i.a. EUSOMA.
World Journal of Surgery
In 2007 I was appointed to the Editors Board of the World Journal of Surgery (WJS),
the official organ of the International Society of Surgery and one of the leading surgical
journals worldwide (cf. BSI). Globally renowned surgeons compose this Board.
Articles in WJS deal with progress in clinical and experimental surgery, surgical training,
and also socioeconomic aspects of surgical care.
Further activities
-
Assessor and Board Member services: American Journal of Cancer, Annals of Oncology,
The Breast, Cancer Research UK, Der Chirurg, Clinical Breast Cancer, International
Journal of Surgery, Journal of Clinical Oncology, Journal of the American Medical
Association, The Lancet, Langenbecks Archiv für Chirurgie, Nature Clinical Practice
Oncology, Onkologie, Womens Health
-
Consultancy in numerous advisory boards and expert panels
|
|
|
back
|
Welcome Page
Personal development
Office
Positions
Activities
Holistic perspective
Calendar
|
|